EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT

EyePoint Pharmaceuticals (EYPT) Financial Statements

773 Followers

EyePoint Pharmaceuticals Financial Overview

EyePoint Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.826; its P/E ratio is -5.24; EyePoint Pharmaceuticals is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 11.68M$ 15.20M$ 5.27M$ 7.68M$ 10.53M
Gross Profit$ 10.93M$ 15.20M$ 9.11M$ 7.68M$ 10.53M
EBIT$ -29.28M$ -10.21M$ -18.90M$ -20.35M$ -42.67M
EBITDA$ -28.98M$ -10.09M$ -18.77M$ -20.25M-
Net Income Common Stockholders$ -29.28M$ -12.61M$ -22.92M$ -21.16M$ -43.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 299.35M$ 136.03M$ 142.50M$ 122.47M$ 144.53M
Total Assets$ 329.25M$ 160.04M$ 175.62M$ 154.59M$ 178.97M
Total Debt$ 4.62M$ 5.18M$ 5.46M$ 40.39M$ 45.77M
Net Debt$ -294.72M$ -130.85M$ -137.04M$ -82.08M$ -98.76M
Total Liabilities$ 79.31M$ 101.42M$ 118.39M$ 76.20M$ 180.36M
Stockholders Equity$ 249.93M$ 58.62M$ 57.26M$ 78.39M$ 96.37M
Cash Flow-
Free Cash Flow$ -32.37M$ -16.92M$ 56.63M$ -17.32M$ -13.08M
Operating Cash Flow$ -31.17M$ -15.20M$ 57.02M$ -16.84M$ -12.49M
Investing Cash Flow$ 20.81M$ -1.72M$ 13.47M$ 32.09M$ 32.92M
Financing Cash Flow$ 115.00K$ 10.36M$ -36.66M$ -5.12M$ -58.00K
Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History

EyePoint Pharmaceuticals Debt to Assets

EyePoint Pharmaceuticals Cash Flow

EyePoint Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis